Sat, 08/10/2024 - 15:34 Gizmodo Lykos, the developer of the MDMA-assisted therapy for PTSD, called the FDA's request for more phase 3 research "deeply disappointing." Tags health, ecstasy, FDA, Lykos, MDMA, molly Source FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns
